This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Joseph Brower
Advertisement
Articles by Joseph Brower
The VERISEQ nucleation technology offers a commercially viable technique for cryogenically generating a uniform dispersion of microscopic ice crystals (or ice-fog).
Advertisement
Latest Updated Articles
- New Developments in Controlled Nucleation: VERISEQ Nucleation Technology
Published: May 8th 2015 | Updated:
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case StudyPublished: May 15th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
